ESC guidance for management of CV disease during the COVID-19 pandemic

ESC guidance for management of CV disease during the COVID-19 pandemic

The Europen Society of Cardiology (ESC) published a detailed guidance for all cardiologists in Europe for the diagnosis and management of CV Disease during the COVID-19 pandemic. You will be able to discover:

  • The best available knowledge on treating the coronavirus infection;
  • Managing cardiovascular conditions in COVID-19 patients;
  • Organising and prioritising care.


ESC has assembled a group of experts with experience in the care of COVID-19 patients to provide a guidance document relevant for all aspects of CV care. ESC pointed out what are the document’s limitations:

“The document is not a guideline but rather a guidance document.


  • The recommendations are the result of observations and personal experience from health care providers at the forefront of the COVID-19 pandemic. Current evidence related to SARS-CoV 2 and its disease manifestations is observational and prospectively designed interventions are missing to form the basis for evidence-based recommendations;
  • This guidance document does not replace any of the official ESC guidelines and is valid only as long as the pandemic status is maintained by the World Health Organization (WHO);
  • This guidance document does not override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, and the final decisions concerning an individual patient must be made by the physician(s) responsible;
  • The guidance provided in the document should in no way interfere with recommendations provided by local and national health care authorities;
  • The pandemic represents a moving target with peak and plateau reached at various timepoints in different regions worldwide. Accordingly, some aspects discussed in this document may only apply to regions most heavily affected by the COVID-19 pandemic, whereas other criteria may apply to less affected geographies;
  • The document provides only a snapshot with preliminary information that may change and mature over time with increasing knowledge, evidence from prospective studies and changes in the pandemic. Therefore, comments may be placed on the website that may be considered by the authors for future updates;
  • Currently there is no evidence-based treatment of COVID-19 infections and experimental treatment may have cardiac side-effects. We encourage experimental treatments to be part of controlled trials whenever possible.”